• Monday, Nov 29, 2021
  • Last Update : 11:02 am

Covid vaccine: Under pressure, Serum Institute of India asks govt for additional ₹30bn

  • Published at 03:58 pm April 7th, 2021
AstraZeneca COVISHIELD
File Photo: Vials of AstraZeneca's COVISHIELD, coronavirus disease vaccine are seen inside a visual inspection machine inside a lab at the Serum Institute of India, in Pune, India, 30 November 2020. Picture taken November 30, 2020. Reuters

AstraZeneca as reportedly served a legal notice to Serum Institute of India over vaccine delays

The world's largest vaccine maker has appealed to the Indian government for financial help after New Delhi restricted exports of its coronavirus jabs to battle a surge in cases at home.

Poorer countries around the world, as well as some rich nations, have relied heavily on the Serum Institute of India (SII) for supplies of the AstraZeneca vaccine but last month the government put the brakes on allowing it to export the shots.

Adar Poonawalla, SII's chief executive, told Indian broadcaster NDTV on Tuesday that since New Delhi pays it less per shot than it earns from exports, it needs 30 billion rupees from the government to boost its currently "very stretched" production capacity.

"This was never budgeted or planned initially because we were supposed to export and get the funding from export countries but now that that is not happening, we have to find other innovative ways to build our capacity," Poonawalla said.

"The globe needs this vaccine and we are prioritizing the needs of India at the moment and we are still short of being able to supply... to every Indian that needs it," he said.

SII, which produces over two million doses of Covishield -- the local name for the AstraZeneca vaccine -- a day, is providing the jab at a subsidized rate of around 150 rupees to India, significantly less than what it charges for exports.

"The price that is set is profitable, however, it is not profitable enough to re-invest substantially in building capacity," Poonawalla said.

US export ban

The company has also been sent a legal notice by AstraZeneca over the delays, which Poonawalla is trying to resolve "amicably", he told the Business Standard in a separate interview published on Wednesday.

"I don't think anybody would want to be in my position today where every head of state has to be explained that I am prioritizing my country because there is a surge in cases," he told the paper.

A US ban on exporting raw materials for vaccines has added to the challenges, especially hitting SII's production of the Covid jab developed by US firm Novavax, he told the newspaper.

"From this month onwards, whatever we stockpile of Novavax would be half of what we could do, had it not been for US restrictions," he said.

"This is as good as banning vaccines."

SII -- which recorded annual revenues of over $800 million in 2019-20 -- has seen its profile soar since the pandemic, with several countries including Britain, Brazil, and South Africa clamouring to buy its vaccine.

The firm has also struck a deal to supply 200 million doses to Covax, a World Health Organization-backed effort to procure and distribute inoculations to poor countries. 

India began vaccinating people aged over 45 last week, aiming to inoculate 300 million people by August. So far it has administered around 87 million shots.

In hard-hit Maharashtra -- home to financial and film capital Mumbai -- vaccine shortages have already forced officials to turn people away, the state's health minister Rajesh Tope told reporters, warning that supplies would dry up in three days unless New Delhi replenished them soon.

India recorded over 100,000 cases in a single day for the first time on Monday, with Mumbai, Delhi, and other cities imposing new curbs on movement and public gatherings in response to the spike.

52
Facebook 51
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail